SB
Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
---|---|---|---|---|---|---|---|
A Systematic Review and Meta-Analysis of HCV Clearance | Liver international | 2017 | 517 | 1 | |||
Weighted Genetic Risk Scores and Prediction of Weight Gain in Solid Organ Transplant Populations | PloS one | 2016 | 482 | 213 | |||
Polymorphisms in the lectin pathway of complement activation influence the incidence of acute rejection and graft outcome after kidney transplantation | Kidney international | 2016 | 455 | 479 | |||
PTX3 Polymorphisms and Invasive Mold Infections After Solid Organ Transplant | Clinical infectious diseases | 2015 | 502 | 1 | |||
Corrigendum: reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes | Nature communications | 2015 | 534 | 144 | |||
Influence of IFNL3/4 Polymorphisms on the Incidence of Cytomegalovirus Infection After Solid-Organ Transplantation | The Journal of infectious diseases | 2015 | 635 | 0 | |||
IL1B and DEFB1 Polymorphisms Increase Susceptibility to Invasive Mold Infection After Solid-Organ Transplantation | The Journal of infectious diseases | 2015 | 582 | 2 | |||
The novel ss469415590 variant predicts virological response to therapy in patients with chronic hepatitis C virus type 1 infection | Alimentary pharmacology & therapeutics | 2014 | 574 | 0 | |||
The IFNL3/4 ΔG variant increases susceptibility to cytomegalovirus retinitis among HIV-infected patients | AIDS | 2014 | 479 | 0 | |||
Reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes | Nature communications | 2014 | 580 | 1,183 | |||
Genetic analyses reveal a role for vitamin D insufficiency in HCV-associated hepatocellular carcinoma development | PloS one | 2013 | 639 | 596 | |||
Comparative genetic analyses point to HCP5 as susceptibility locus for HCV-associated hepatocellular carcinoma | Journal of hepatology | 2013 | 605 | 0 | |||
IL28B expression depends on a novel TT/-G polymorphism which improves HCV clearance prediction | The Journal of experimental medicine | 2013 | 534 | 0 | |||
IL28B polymorphisms predict response to therapy among chronic hepatitis C patients with HCV genotype 4 | Journal of viral hepatitis | 2013 | 587 | 0 | |||
IL28B polymorphisms do not predict response to therapy in chronic hepatitis C with HCV genotype 5 | Gut | 2012 | 551 | 0 | |||
Serum ferritin levels are associated with a distinct phenotype of chronic hepatitis C poorly responding to pegylated interferon-alpha and ribavirin therapy | Hepatology | 2012 | 547 | 0 | |||
A genetic validation study reveals a role of vitamin D metabolism in the response to interferon-alfa-based therapy of chronic hepatitis C | PloS one | 2012 | 679 | 349 | |||
IL28B alleles associated with poor hepatitis C virus (HCV) clearance protect against inflammation and fibrosis in patients infected with non-1 HCV genotypes | Hepatology | 2012 | 615 | 0 | |||
Genome-wide association study identifies variants associated with progression of liver fibrosis from HCV infection | Gastroenterology | 2012 | 579 | 0 | |||
The impact of fibrosis and steatosis on early viral kinetics in HCV genotype 1-infected patients treated with Peg-IFN-alfa-2a and ribavirin | Journal of viral hepatitis | 2012 | 564 | 0 | |||
IL28B polymorphisms predict reduction of HCV RNA from the first day of therapy in chronic hepatitis C | Journal of hepatology | 2011 | 557 | 0 | |||
Response prediction in chronic hepatitis C by assessment of IP-10 and IL28B-related single nucleotide polymorphisms | PloS one | 2011 | 575 | 276 |